scholarly journals Response Predictors in Chronic Migraine: Medication Overuse and Depressive Symptoms Negatively Impact Onabotulinumtoxin-A Treatment

2019 ◽  
Vol 10 ◽  
Author(s):  
Francesca Schiano di Cola ◽  
Salvatore Caratozzolo ◽  
Paolo Liberini ◽  
Renata Rao ◽  
Alessandro Padovani
Keyword(s):  
Depressive Symptoms ◽  
Chronic Migraine ◽  
Medication Overuse ◽  
Response Predictors ◽  
Onabotulinumtoxin A ◽  
Migraine Medication

scholarly journals Correlation between migraine subtipes and depression

2008 ◽  
Vol 66 (3a) ◽  
pp. 485-487 ◽  
Author(s):  
Renan Barros Domingues ◽  
Esther Angélica Coelho Costa ◽  
Ariovaldo da Silva Jr ◽  
Simone Aires Domingues ◽  
Juliana Cardoso Leal ◽  
...  
Keyword(s):  
Depressive Symptoms ◽  
Chronic Migraine ◽  
Beck Depression Inventory ◽  
Medication Overuse ◽  
Episodic Migraine ◽  
The Mean ◽  
Asymptomatic Subjects

This study has evaluated depression in patients with episodic migraine (n=98), chronic migraine without medication overuse (n=23), and chronic migraine with medication overuse (n=57). The Beck Depression Inventory (BDI) was used to evaluate depressive symptoms in these three groups. The mean BDI score obtained in all patients was higher than that observed in asymptomatic subjects (episodic migraine=16.09±11.79, chronic migraine with medication overuse=18.91±12.53, chronic migraine without medication overuse=19.83±14.79). This finding corroborates previous studies suggesting a co-morbid association between migraine and depression. Depression did not seem to be crucial in the transformation of migraine as the median BDI scores did not differ significantly between patients with episodic and chronic migraine. The median BDI scores of the patients with chronic migraine with medication overuse and that patients with chronic migraine without medication overuse were similar as well. Therefore, medication overuse behavior may not be related with depression.

86. Onabotulinumtoxin-A treatment in chronic migraine with medication overuse: A two years Italian experience

2017 ◽  
Vol 128 (12) ◽  
pp. e435
Author(s):  
C. Butera ◽  
B. Colombo ◽  
F. Bianchi ◽  
S. Amadio ◽  
R. Guerriero ◽  
...  
Keyword(s):  
Chronic Migraine ◽  
Medication Overuse ◽  
Italian Experience ◽  
Onabotulinumtoxin A

Onabotulinumtoxin A for chronic migraine with medication overuse: clinical results and changes in catastrophising attitude. Preliminary data

2018 ◽  
Vol 39 (S1) ◽  
pp. 173-174 ◽  
Author(s):  
Licia Grazzi ◽  
Eleonora Grignani ◽  
Emanuela Sansone ◽  
Alberto Raggi ◽  
Matilde Leonardi ◽  
...  
Keyword(s):  
Chronic Migraine ◽  
Preliminary Data ◽  
Medication Overuse ◽  
Clinical Results ◽  
Onabotulinumtoxin A

Disability in Chronic Migraine Patients With Medication Overuse: Treatment Effects at 1‐Year Follow‐up

2004 ◽  
Vol 44 (7) ◽  
pp. 678-683 ◽  
Author(s):  
Licia Grazzi ◽  
Frank Andrasik ◽  
Domenico D'Amico ◽  
Susanna Usai ◽  
Steven Kass ◽  
...  
Keyword(s):  
Chronic Migraine ◽  
Treatment Effects ◽  
Medication Overuse

scholarly journals Migraine

2021 ◽  
Vol 9 (12) ◽  
pp. 1407-1427
Author(s):  
Mr. Ghene Mauli Ganesh
Keyword(s):  
Chronic Migraine ◽  
Medication Overuse ◽  
Treatment Options ◽  
Preventive Treatment ◽  
Primary Headaches ◽  
Brain Disorder ◽  
Current State ◽  
The Common ◽  
Chronic Headaches ◽  
Migrainous Headache

Abstract: Migraine is the most common disabling brain disorder. Chronic migraine, a condition characterized by the experience of migrainous headache on at least 15 days per month, is highly disabling. Patients with chronic migraine present to primary care, are often referred for management to secondary care, and make up a large proportion of patients in specialist headache clinics. Many patients with chronic migraine also have medication overuse, defined as using a compound analgesic, opioid, triptan or ergot derivative on at least 10 days per month. All doctors will encounter patients with chronic headaches. A basic working knowledge of the common primary headaches, and a rational manner of approaching the patient with these conditions, allows a specific diagnosis of chronic migraine to be made quickly and safely, and by making this diagnosis one opens up a substantial number of acute and preventive treatment options. This article discusses the current state of management of chronic migraine.

scholarly journals Orbitofrontal dysfunction predicts poor prognosis in chronic migraine with medication overuse

2011 ◽  
Vol 12 (4) ◽  
pp. 459-466 ◽  
Author(s):  
Marian Gómez-Beldarrain ◽  
María Carrasco ◽  
Amaia Bilbao ◽  
Juan C. García-Moncó
Keyword(s):  
Chronic Migraine ◽  
Poor Prognosis ◽  
Medication Overuse

scholarly journals Real‐World Economic Impact of Onabotulinumtoxin A in Patients With Chronic Migraine

2014 ◽  
Vol 54 (10) ◽  
pp. 1565-1573 ◽  
Author(s):  
John F. Rothrock ◽  
Lisa M. Bloudek ◽  
Timothy T. Houle ◽  
Diane Andress‐Rothrock ◽  
Sepideh F. Varon
Keyword(s):  
Economic Impact ◽  
Chronic Migraine ◽  
Real World ◽  
Onabotulinumtoxin A ◽  
World Economic
Sign in / Sign up

Export Citation Format

Share Document